chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Amnesia, Fatigue
Clinical narrative: she's been noticing memory loss that is getting worse/having problems remembering; chronic fatigue; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 52 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 02Jul2021 (Lot number: FA6780) at the age of 52 years as dose 1, single and administered in arm left, administration date 23Jul2021 (Lot number: FA6780) as dose 2, single for covid-19 immunisation. Relevant medical history included: "ADD" (unspecified if ongoing); "Epstein Barr" (unspecified if ongoing), notes: Epstein Barr: was diagnosed either about 1984 or 1985; "Allergies: Latex" (unspecified if ongoing), notes: Allergies: Latex; "spine surgeries", start date: 2018 (unspecified if ongoing), notes: she had spine surgeries and the last one was in 2018. Concomitant medication(s) included: BACLOFEN; MODAFINIL taken for attention deficit hyperactivity disorder. Past drug history included: Cipro, reaction(s): "Allergies: Cipro", notes: Allergies: Cipro; Steroids, reaction(s): "Allergies: very very vey intolerant to any steroids", notes: Allergies: very very vey intolerant to any steroids. The following information was reported: AMNESIA (non-serious) with onset 2021, outcome "not recovered", described as "she's been noticing memory loss that is getting worse/having problems remembering"; FATIGUE (non-serious) with onset 2021, outcome "recovering", described as "chronic fatigue". Therapeutic measures were taken as a result of fatigue.  Additional Information: Caller states that she is calling in regards to the Pfizer Covid Vaccine. She is athletic, healthy, almost 53 year old woman. She takes good care of her self. Since the final vaccine her memory is very bad and it is starting to scare her. She had Mono as a child, but its like its reactivated. She has not had this in a long time. She is scared, she works in Medical field, she is college educated. Like she didn't know yesterday was Monday, she even overdrawn on her checking account, she is not a wacky person, she has the funds, she has thousands but she is not focused, and her memory is now really bad. She was calling about the side effect, when she had Mono, or more specifically she knows she has Epstein Barr in the blood, her doctor waited a long time for her to get the vaccine, she was afraid that she might have the problem. She has questions if there is other studies that have information about the vaccine and the Epstein Barr or anything similar to that, or that the vaccine may have escalated or reactivated a condition. She wasn't sick for years and she is healthy, thin, eats well, doesn't do drugs. Her Mom's a nurse, her dads a retired doctor, and she herself works in devices.  No follow-up attempts are possible. No further information is expected.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Was a little achy; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 71 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 23Feb2021 (Lot number: EN6200, Expiration Date: 20Jun2021) at the age of 71 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Allergies" (unspecified if ongoing), notes: Verbatim: Allergies; "Sinus problems" (unspecified if ongoing), notes: Verbatim: Sinus problems; "Aches and pains" (unspecified if ongoing), notes: Verbatim: Aches and pains; "Neuropathy" (unspecified if ongoing). There were no concomitant medications. The following information was reported: PAIN (non-serious) with onset 2021, outcome "unknown", described as "Was a little achy".  No follow-up attempts are possible. No further information is expected.  Follow-up (12Jan2022): Follow-up attempts completed. No further information expected.
Sex: M
Vaccine: COVID19
Symptoms: Pain, Vaccination site pain
Clinical narrative: The only side effect was he had was tenderness at the shot but not deep pain like with the other shots; the experience after the first 2 shots he declines saying it was the normal pain after a shot; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 41 year-old male patient received bnt162b2 (BNT162B2), administration date 08Apr2021 (Lot number: EW0150) as dose 1, single and administration date 29Apr2021 (Lot number: EW1067) as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 2021, outcome "unknown", described as "The only side effect was he had was tenderness at the shot but not deep pain like with the other shots"; PAIN (non-serious) with onset 2021, outcome "unknown", described as "the experience after the first 2 shots he declines saying it was the normal pain after a shot".  Additional Information:  No previous immunization with the Pfizer vaccine considered as suspect. No Additional Vaccines Administered on Same Date of the Pfizer Suspect. No treatment as result of events. Patient not went to emergency room or physician office as result of events. No Relevant Tests. Reporter provided details regarding the experience after the first 2 shots, he declines saying it was the normal pain after a shot, it was not serious just deeper than the booster.   No Follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Myalgia
Clinical narrative: He had maybe some slight fatigue, muscle soreness the first few days after both shots; He had maybe some slight fatigue, muscle soreness the first few days after both shots; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 23Apr2021 (Lot number: EW0171) as dose 1, single and administered in arm left, administration date 17May2021 (Lot number: EW0183) as dose 2, single for covid-19 immunisation. Relevant medical history included: "muscle relaxer" (unspecified if ongoing). Concomitant medication(s) included: METHOCARBAMOL taken for muscle relaxant therapy; FLU. The following information was reported: FATIGUE (non-serious), MYALGIA (non-serious) all with onset Apr2021, outcome "recovered" (2021) and all described as "He had maybe some slight fatigue, muscle soreness the first few days after both shots".  No follow-up attempts are possible. No further information is expected.  Follow-up (06Jan2022): Follow-up attempts completed. No further information expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Ear discomfort
Clinical narrative: she had a burning sensation up her arm and down her neck /she had burning sensation in her arm where she received her injection on the left side; It went up to her ear on left side/she had burning sensation in her arm where she received her injection on the left side and went up to her ear; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 65 year-old female patient received bnt162b2 (BNT162B2), administration date 12Feb2021 (Lot number: EN9809) at the age of 65 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: BURNING SENSATION (non-serious) with onset 2021, outcome "recovered" (2021), described as "she had a burning sensation up her arm and down her neck /she had burning sensation in her arm where she received her injection on the left side"; EAR DISCOMFORT (non-serious) with onset 2021, outcome "recovered" (2021), described as "It went up to her ear on left side/she had burning sensation in her arm where she received her injection on the left side and went up to her ear".  Additional Information: After her first dose, she had burning sensation in her arm where she received her injection on the left side and went up to her ear, lasted a few minutes.   No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (159558). The reporter is the patient.  A 61 year-old male patient received bnt162b2 (BNT162B2), administration date Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "unknown", described as "sore arm".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Menstrual disorder
Clinical narrative: Her second vaccine it happened, but she was due for her period at that time. She was on a different birth control then , and still had periods.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 34 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 07Mar2021 (Lot number: EN6206) at the age of 34 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "severe asthma" (unspecified if ongoing), notes: Verbatim: severe asthma. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (1st dose, lot number: EN6201, administered in left arm), administration date: 14Feb2021, when the patient was 33 years old, reaction(s): "Covid-19 Vaccination". The following information was reported: MENSTRUAL DISORDER (non-serious), outcome "unknown", described as "Her second vaccine it happened, but she was due for her period at that time. She was on a different birth control then , and still had periods.". The event "her second vaccine it happened, but she was due for her period at that time. she was on a different birth control then , and still had periods." was evaluated at the physician office visit.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Pain, Pain in extremity
Clinical narrative: she feel like a little bad for a couple of days; more harsh, more pain, more everything and it hurts; it has pain again like in ''hand''; today it is going more harsh, more pain, more everything and it hurts; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP).  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (1ST DOSE), for COVID-19 immunization. The following information was reported: FEELING ABNORMAL (non-serious), outcome "unknown", described as "she feel like a little bad for a couple of days"; PAIN (non-serious), outcome "unknown", described as "more harsh, more pain, more everything and it hurts"; PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "it has pain again like in ''hand''; today it is going more harsh, more pain, more everything and it hurts".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal
Clinical narrative: This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient. A 61 year-old male patient received bnt162b2 (BNT162B2), administration date 2021 (Batch/Lot number: unknown) as dose 2, single for Covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1, sometime in April), administration date: Apr2021, for Covid-19 Immunization, reaction(s): "sore arm". The following information was reported: FEELING ABNORMAL (non-serious) with onset 2021, outcome "recovered" (2021), described as "brain fog". Additional information: Reporter stated he had a "sore arm" after first shot, received "sometime in April". Reporter stated that he had second shot at recommended interval on a Thursday and Friday "within a day" he had "brain fog", "didn't feel quite myself" "couldn't concentrate very much" and this resolved approximately on Sunday. Reporter queried for if booster shot was the same as primary series. In response to the query it was provided that Yes. COVID-19 booster shots are the same formulation as the current COVID-19 vaccines. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Blood test, Body temperature, Chest discomfort, Chest pain
Clinical narrative: This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.A 24 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 01Jul2021 (Lot number: EW0217) at the age of 24 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications.The following information was reported: HEADACHE (non-serious) with onset Jul2021, outcome "recovered" (2021), described as "headache"; FATIGUE (non-serious), outcome "recovered", described as "tired/He was feeling so tired"; CHEST DISCOMFORT (non-serious), outcome "unknown", described as "chest pressure/felt something in his chest"; MUSCULOSKELETAL DISCOMFORT (non-serious), outcome "unknown", described as "chest pressure went to my back"; PYREXIA (non-serious) with onset Jul2021, outcome "unknown", described as "fever"; CHEST PAIN (non-serious) with onset Jul2021, outcome "recovered", described as "Chest pain"; BACK PAIN (non-serious) with onset Jul2021, outcome "recovered" (2021), described as "Back Pain"; CHEST DISCOMFORT (non-serious) with onset Jul2021, outcome "unknown", described as "Pressure"; FEEDING DISORDER (non-serious) with onset Jul2021, outcome "recovered", described as "was not able to eat"; ILLNESS (non-serious), FEELING ABNORMAL (non-serious), outcome "unknown" and all described as "he became ill, he felt bad". The events "headache", "tired/he was feeling so tired", "chest pressure/felt something in his chest", "chest pressure went to my back", "fever", "chest pain", "back pain", "pressure", "was not able to eat", "he became ill, he felt bad" and "he became ill, he felt bad" were evaluated at the physician office visit and emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of headache, fatigue, chest discomfort, musculoskeletal discomfort, pyrexia.Additional information: Is report related to a study or programme- No. Patient clarified he went to the Emergency Room on 21Jul2021. Patient confirmed he received the second dose on 25Jul2021. He asked the physician about if okay to get, about if knew felt bad with first one, and physician okayed to get second dose. The patient did not administer additional Vaccines on Same Date of the Pfizer Suspect.No follow-up attempts are possible. No further information is expected.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Feeding disorder, Feeling abnormal, Headache, Illness
Clinical narrative: This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.A 24 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 01Jul2021 (Lot number: EW0217) at the age of 24 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications.The following information was reported: HEADACHE (non-serious) with onset Jul2021, outcome "recovered" (2021), described as "headache"; FATIGUE (non-serious), outcome "recovered", described as "tired/He was feeling so tired"; CHEST DISCOMFORT (non-serious), outcome "unknown", described as "chest pressure/felt something in his chest"; MUSCULOSKELETAL DISCOMFORT (non-serious), outcome "unknown", described as "chest pressure went to my back"; PYREXIA (non-serious) with onset Jul2021, outcome "unknown", described as "fever"; CHEST PAIN (non-serious) with onset Jul2021, outcome "recovered", described as "Chest pain"; BACK PAIN (non-serious) with onset Jul2021, outcome "recovered" (2021), described as "Back Pain"; CHEST DISCOMFORT (non-serious) with onset Jul2021, outcome "unknown", described as "Pressure"; FEEDING DISORDER (non-serious) with onset Jul2021, outcome "recovered", described as "was not able to eat"; ILLNESS (non-serious), FEELING ABNORMAL (non-serious), outcome "unknown" and all described as "he became ill, he felt bad". The events "headache", "tired/he was feeling so tired", "chest pressure/felt something in his chest", "chest pressure went to my back", "fever", "chest pain", "back pain", "pressure", "was not able to eat", "he became ill, he felt bad" and "he became ill, he felt bad" were evaluated at the physician office visit and emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of headache, fatigue, chest discomfort, musculoskeletal discomfort, pyrexia.Additional information: Is report related to a study or programme- No. Patient clarified he went to the Emergency Room on 21Jul2021. Patient confirmed he received the second dose on 25Jul2021. He asked the physician about if okay to get, about if knew felt bad with first one, and physician okayed to get second dose. The patient did not administer additional Vaccines on Same Date of the Pfizer Suspect.No follow-up attempts are possible. No further information is expected.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Investigation, Musculoskeletal discomfort, Pyrexia, X-ray
Clinical narrative: This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.A 24 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 01Jul2021 (Lot number: EW0217) at the age of 24 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications.The following information was reported: HEADACHE (non-serious) with onset Jul2021, outcome "recovered" (2021), described as "headache"; FATIGUE (non-serious), outcome "recovered", described as "tired/He was feeling so tired"; CHEST DISCOMFORT (non-serious), outcome "unknown", described as "chest pressure/felt something in his chest"; MUSCULOSKELETAL DISCOMFORT (non-serious), outcome "unknown", described as "chest pressure went to my back"; PYREXIA (non-serious) with onset Jul2021, outcome "unknown", described as "fever"; CHEST PAIN (non-serious) with onset Jul2021, outcome "recovered", described as "Chest pain"; BACK PAIN (non-serious) with onset Jul2021, outcome "recovered" (2021), described as "Back Pain"; CHEST DISCOMFORT (non-serious) with onset Jul2021, outcome "unknown", described as "Pressure"; FEEDING DISORDER (non-serious) with onset Jul2021, outcome "recovered", described as "was not able to eat"; ILLNESS (non-serious), FEELING ABNORMAL (non-serious), outcome "unknown" and all described as "he became ill, he felt bad". The events "headache", "tired/he was feeling so tired", "chest pressure/felt something in his chest", "chest pressure went to my back", "fever", "chest pain", "back pain", "pressure", "was not able to eat", "he became ill, he felt bad" and "he became ill, he felt bad" were evaluated at the physician office visit and emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of headache, fatigue, chest discomfort, musculoskeletal discomfort, pyrexia.Additional information: Is report related to a study or programme- No. Patient clarified he went to the Emergency Room on 21Jul2021. Patient confirmed he received the second dose on 25Jul2021. He asked the physician about if okay to get, about if knew felt bad with first one, and physician okayed to get second dose. The patient did not administer additional Vaccines on Same Date of the Pfizer Suspect.No follow-up attempts are possible. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Menstruation irregular
Clinical narrative: Menstrual cycle every 2 weeks; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 28 year-old female patient received bnt162b2 (COMIRNATY), administered in arm left, administration date 10Sep2021 (Lot number: 301308A) at the age of 28 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (COVID-19 Vaccine: First dose: , Date: 18Aug2021, Manufacturer: Pfizer , NDC/EXP: Unknown , LOT: EW0217; states the person who documented this lot number has terrible handwriting. , Route: Upper left arm, right below the shoulder. , Formulation: injection/shot), administration date: 18Aug2021, when the patient was 28 years old, for Covid-19 Immunization.  The following information was reported: MENSTRUATION IRREGULAR (non-serious) with onset 2021, outcome "unknown", described as "Menstrual cycle every 2 weeks". The event "menstrual cycle every 2 weeks" was evaluated at the physician office visit. Therapeutic measures were taken as a result of menstruation irregular.   Additional information: The patient began a menstrual cycle on 11Sep2021, by Oct2021, she started realizing her menstrual cycles were not normal.  Menstrual cycles were lasting longer than normal, 8-9 days. She went to her gynecologist two weeks ago and was given a pill. It was a 10 day pill. Caller's gynecologist stated it would stop the bleeding and hopefully restart caller's menstrual cycle.  Caller was told this pill is like taking 2 birth control pills at once. Caller states she was a psychopath on birth control. Caller does not provide any product names for the birth control she mentioned. She took one of these pills her gynecologist gave her and didn't take any more. States this was not this past week, but the week before. Caller started her menstrual cycle again today. The patient did not take any other vaccines within four weeks Prior Vaccinations.   No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101850382 same reporter and event, different patients
Sex: F
Vaccine: COVID19
Symptoms: Sinus pain
Clinical narrative: This is a solicited report received from contactable reporter(s) (Consumer or other non HCP) for a sponsored program. The reporter is the patient. Other Case identifier(s): 21K-163-4203909-00 (RA). A 54 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administration date May2021 (Batch/Lot number: unknown) as dose 1, single for Covid-19 immunisation; upadacitinib (RINVOQ), oral since 01Nov2021 (ongoing) (Batch/Lot number: unknown) for rheumatoid arthritis. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: RHEUMATOID ARTHRITIS (medically significant) with onset 2022, outcome "unknown", described as "RHEUMATOID ARTHRITIS FLARE"; BLOOD PRESSURE INCREASED (non-serious) with onset 2021, outcome "not recovered", described as "blood pressure had been higher than usual/Her most recent blood pressure reading were 132/88 and 155/100/ Increased blood pressure"; PALPITATIONS (non-serious) with onset Nov2021, outcome "not recovered", described as "HEART PALPITATIONS OCCASIONALLY"; SINUS PAIN (non-serious), outcome "unknown", described as "Sinus pain"; HEADACHE (non-serious), outcome "unknown", described as "HEADACHES". The event "rheumatoid arthritis flare" was evaluated at the physician office visit. The patient underwent the following laboratory tests and procedures: blood pressure measurement: (Dec2021) 132/88; (Dec2021) 155/100. The action taken for upadacitinib was dosage not changed. Causality for Rinvoq (upadacitinib): The reporter's causality for the event(s) of increased blood pressure, heart palpitations occasionally, sinus pain, headaches and rheumatoid arthritis flare was not provided. Causality for Pfizer BioNTech Covid-19 vaccine (tozinameran): The reporter's causality for the event(s) of increased blood pressure was possible, heart palpitations occasionally, sinus pain, headaches and rheumatoid arthritis flare was not related. Follow-up (09Mar2022): This is a solicited Follow-up report based on information received by Pfizer (Manufacturer Control Number: 21K-163-4203909-00). Updated information included: patient demographics, event information, reporter opinion of causality, suspect drug information and narrative description. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected. Sender's Comments: Based on the Limited information available and close temporal association, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported event. The case will be reassessed once new information is available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Sex: M
Vaccine: COVID19
Symptoms: Atrophy, Jaw disorder, Muscle atrophy
Clinical narrative: made my jaw shrink; my muscles atrophy; I suffer from more atrophy; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 38 year-old male patient received bnt162b2 (BNT162B2), administration date 22Dec2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "my teeth were shaved" (unspecified if ongoing); "atrophy" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: JAW DISORDER (non-serious) with onset Dec2021, outcome "unknown", described as "made my jaw shrink"; MUSCLE ATROPHY (non-serious) with onset Dec2021, outcome "unknown", described as "my muscles atrophy"; ATROPHY (non-serious) with onset Dec2021, outcome "unknown", described as "I suffer from more atrophy".  Additional information: Additional information: patient have a smaller chin because of it.Patient a professional fighter. The Pfizer vaccination may have ruined my career and my life or at least contributed to it. Patient was not going to get it but because its so hard to move around with the covid virus, patient got it so can travel freely". The patient reports " chin were literally, when patient rub face and chin was so high up, patient don't have a chin anymore, patient so boney, all my muscles atrophied, what patient supposed to do How supposed to get compensated. patient supposed to get a second vaccination and then what, then my chin really disappear and patient have no chin should be compensated." The patient reports that just saw several oral maxiofacial surgeons in several countries because 15 months ago patient was the victim of malpractice, teeth were shaved, it was improper practice, pateint didn't need to have them shaved. Once the enamel is secreted the bone re absorbs, after that atrophy kicked in, over time more atrophy kicked in, now patient lost all of muscles and look like an old person. patient got the coronavirus vaccination and suffer from more atrophy. "This vaccination screwed me up even more. "The patient declined to file a safety report. Declined to provide name or contact information. The patient went on to say "I noticed this before the vaccine. All the people that advertise for the vaccination, have disgusting smiles, their lips are ripped open, they have poor bone, they aren't the type of people getting punched in the face, they aren't strong people. Then I get the vaccination and my jaw shrinks more, after patient victim of malpractice.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Dry mouth, Feeling abnormal, Tongue discomfort
Clinical narrative: Dry mouth; My tongue is stuck to the roof of my mouth; I feel like it did something to me/ I am really afraid/ terrible; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 55 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date Apr2021 (Lot number: EW0153) at the age of 54 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: ESTRADIOL. Vaccination history included: Bnt162b2 (Dose 1, Lot number: ER8730, Anatomical location: Left arm), administration date: Mar2021, when the patient was 54 years old, for COVID-19 immunization. The following information was reported: DRY MOUTH (non-serious) with onset 2021, outcome "unknown", described as "Dry mouth"; TONGUE DISCOMFORT (non-serious) with onset 2021, outcome "unknown", described as "My tongue is stuck to the roof of my mouth"; FEELING ABNORMAL (non-serious) with onset 2021, outcome "unknown", described as "I feel like it did something to me/ I am really afraid/ terrible". The events "dry mouth", "my tongue is stuck to the roof of my mouth" and "i feel like it did something to me/ i am really afraid/ terrible" were evaluated at the physician office visit. Therapeutic measures were taken as a result of dry mouth, tongue discomfort, feeling abnormal.  Additional information: The facility where the most recent COVID-19 vaccine was administered was Pharmacy. The patient had got three COVID vaccines Pfizer. The first two, she went on same Friday and the third, she went on different Friday. She got one in Mar2021, one in Apr2021 and then she got one on 10Dec2021 and sometime after the second one she had developed dry mouth and she thought it might be related to the vaccine. The patient thought that she had developed dry mouth from the vaccine and she didn't know what to do with it and if it was going to be permanent or not permanent. She was really afraid if this was going to be permanent than she was damaged, she was afraid and she felt like it did something to her. The patient went to the dentist because her mouth was terribly dry and she tried dry mouth does not help. The mouth dryness was in the middle of the night, like she woke up and her tongue was stuck to the roof of her mouth, terrible it was just terrible and than her mouth was dry but not as bad as day. It was really bad and mean time, she was afraid her teeth didn't fall out because her mouth was so dry. She never had this, never ever. She called her pharmacist. She went to see her dentist. She had tried the only thing, she tried was the toothpaste.  No follow-up attempts are possible. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Inappropriate schedule of product administration, Pain
Clinical narrative: Covid-19 Vaccine First dose, Date: 05Jan2021; Covid-19 Vaccine Second dose Date: 22Jan2021; achy; tired; This is a spontaneous report received from contactable reporter(s) (Other HCP) from medical information team. The reporter is the patient.  A 37 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 05Jan2021 (Lot number: EK5730) at the age of 37 years as dose 1, single and administered in arm left, administration date 22Jan2021 (Lot number: EL3248) as dose 2, single for covid-19 immunisation. Relevant medical history included: "Psoriasis", start date: 2013 (ongoing); "ADD" (ongoing). Concomitant medication(s) included: CLOBETASOL taken for psoriasis, start date: 2013 (ongoing); VYVANSE taken for attention deficit hyperactivity disorder, start date: 2015 (ongoing). Past drug history included: Adderall for ADD, notes: Used to take Adderall when she was child and switrched to Vivance in 2015. The following information was reported: PAIN (non-serious) with onset Jan2021, outcome "recovered" (Jan2021), described as "achy"; FATIGUE (non-serious) with onset Jan2021, outcome "recovered" (Jan2021), described as "tired"; INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 22Jan2021, outcome "unknown", described as "Covid-19 Vaccine First dose, Date: 05Jan2021; Covid-19 Vaccine Second dose Date: 22Jan2021".  Additional information: Patient reported that with the first and second dose of the Covid-19 vaccine, she was tired and achy, but that was it. The symptoms for that only lasted 12-24 hours though. Patient did not receive any other vaccinations within 4 weeks prior to first administration of covid vaccine.   No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Headache, Platelet count
Clinical narrative: headache; has a history of cherry angioma but felt it became much more pronounced after vaccination.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 43 year-old female patient received bnt162b2 (BNT162B2) (Lot number: EP7533) as dose 1, single for covid-19 immunisation. Relevant medical history included: "cherry angioma" (unspecified if ongoing), notes: she has a history of cherry angioma. The patient's concomitant medications were not reported. The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "headache"; CONDITION AGGRAVATED (non-serious), outcome "unknown", described as "has a history of cherry angioma but felt it became much more pronounced after vaccination.". The event "has a history of cherry angioma but felt it became much more pronounced after vaccination." was evaluated at the emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Reporter stated that she and a friend went together and received Pfizer Covid Vaccines (purple label). Reporter stated that this was her friends first dose, but this was her booster dose. Reporter states that she noticed they both had the same lot numbers. Reporter asked are all three doses of the Pfizer Covid vaccine the same formulation. During call Reporter mentioned that after her second dose of the Pfizer Covid Vaccine she had a fever of 103 degree. Reporter stated that symptoms began approximately 12 hours after injection and she had chills, muscle ache, joint pain and a mild fever that went up. Reporter stated she took Tylenol and Ibuprofen 3-4 times a day. Symptoms resolved in about 48 hours. Symptoms with her first Covid vaccination, Reporter stated, "It was a nightmare." Reporter said that she had a headache and that she has a history of cherry angioma but felt it became much more pronounced after vaccination. Reporter said because of this she went to the Emergency Room to have her platelets checked because she thought maybe they were going up, but they were fine. Reporter provided lot number of first vaccine as EP7533 and lot number of second vaccine as EW0153. Reporter comments that her booster dose was given about 20 min ago and at this point she feels fine.  Follow-up attempts completed. No further information expected.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Colonoscopy normal, Condition aggravated, Endoscopy upper gastrointestinal tract, Gastric emptying study
Clinical narrative: hot flashes; chills; chills got worse; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 21 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 01Sep2021 18:00 (Lot number: FC3182) at the age of 21 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "no taste and smell", start date: 26Dec2020 (unspecified if ongoing); "no taste and smell", start date: 26Dec2020 (unspecified if ongoing); "nausea", start date: 26Dec2020 (unspecified if ongoing); "vomiting", start date: 26Dec2020 (unspecified if ongoing); "passing out", start date: 26Dec2020 (unspecified if ongoing); "hot flashes", start date: 26Dec2020 (unspecified if ongoing); "chills", start date: 26Dec2020 (unspecified if ongoing); "diarrhea", start date: 26Dec2020 (unspecified if ongoing); "abdominal pain", start date: 26Dec2020 (unspecified if ongoing); "headache", start date: 26Dec2020 (unspecified if ongoing); "cramps", start date: 26Dec2020 (unspecified if ongoing); "no period", start date: 26Dec2020 (unspecified if ongoing); "birth control" (unspecified if ongoing). Concomitant medication(s) included: JUNEL FE 1.5/30 taken for contraception, start date: 2018 (ongoing). The following information was reported: HOT FLUSH (non-serious) with onset 01Sep2021 19:00, outcome "not recovered", described as "hot flashes"; CHILLS (non-serious) with onset 01Sep2021 19:00, outcome "not recovered", described as "chills"; CONDITION AGGRAVATED (non-serious) with onset 01Sep2021 19:00, outcome "not recovered", described as "chills got worse". The events "hot flashes", "chills" and "chills got worse" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of hot flush, chills, condition aggravated.  Additional information: Other reported test were CBC, Celiac w reflux, IGA, TSH 3rd, ANA Screen, XR Chest, Lactate dehydrogenase and all are negative. Patient had not received any other vaccine within 4 weeks prior vaccination.  No follow-up attempts are possible. No further information is expected.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Hot flush, SARS-CoV-2 antibody test, Scan
Clinical narrative: hot flashes; chills; chills got worse; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 21 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 01Sep2021 18:00 (Lot number: FC3182) at the age of 21 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "no taste and smell", start date: 26Dec2020 (unspecified if ongoing); "no taste and smell", start date: 26Dec2020 (unspecified if ongoing); "nausea", start date: 26Dec2020 (unspecified if ongoing); "vomiting", start date: 26Dec2020 (unspecified if ongoing); "passing out", start date: 26Dec2020 (unspecified if ongoing); "hot flashes", start date: 26Dec2020 (unspecified if ongoing); "chills", start date: 26Dec2020 (unspecified if ongoing); "diarrhea", start date: 26Dec2020 (unspecified if ongoing); "abdominal pain", start date: 26Dec2020 (unspecified if ongoing); "headache", start date: 26Dec2020 (unspecified if ongoing); "cramps", start date: 26Dec2020 (unspecified if ongoing); "no period", start date: 26Dec2020 (unspecified if ongoing); "birth control" (unspecified if ongoing). Concomitant medication(s) included: JUNEL FE 1.5/30 taken for contraception, start date: 2018 (ongoing). The following information was reported: HOT FLUSH (non-serious) with onset 01Sep2021 19:00, outcome "not recovered", described as "hot flashes"; CHILLS (non-serious) with onset 01Sep2021 19:00, outcome "not recovered", described as "chills"; CONDITION AGGRAVATED (non-serious) with onset 01Sep2021 19:00, outcome "not recovered", described as "chills got worse". The events "hot flashes", "chills" and "chills got worse" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of hot flush, chills, condition aggravated.  Additional information: Other reported test were CBC, Celiac w reflux, IGA, TSH 3rd, ANA Screen, XR Chest, Lactate dehydrogenase and all are negative. Patient had not received any other vaccine within 4 weeks prior vaccination.  No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Oropharyngeal pain
Clinical narrative: sore throat; fatigue; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A child male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: OROPHARYNGEAL PAIN (non-serious), outcome "unknown", described as "sore throat"; FATIGUE (non-serious), outcome "unknown", described as "fatigue".  Additional information: The patient receive any other vaccines within 4 weeks prior to the COVID vaccine was unknown. It was unknown if the patient was diagnosed with COVID-19 prior to vaccination or tested for covid-19 since the vaccination.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Acarodermatitis, Eczema, Rash
Clinical narrative: little bit of rash/ every place on his body; Thought it may be eczema; Scabies; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 21 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: RASH (non-serious), outcome "unknown", described as "little bit of rash/ every place on his body"; ECZEMA (non-serious), outcome "unknown", described as "Thought it may be eczema"; ACARODERMATITIS (non-serious), outcome "unknown", described as "Scabies". The events "little bit of rash/ every place on his body", "thought it may be eczema" and "scabies" were evaluated at the physician office visit. Therapeutic measures were taken as a result of rash, eczema, acarodermatitis.  Additional information: When probed for the concern, reporter stated, "His son (patient) took the Pfizer Vaccine as we all did and probably a week or two week after he took the vaccine he develop a little bit of rash, they thought that was may be eczema they treated it for eczema through the Doctor Program here in and he didn't even touch it, then they treated it for scabies because one of the kid it was presumed had scabies in the Health but that was not clearing up either, the antibiotic Cream that was prescribed (unspecified medication), so last night reporter visited the website and looked at some of the pictures of some of the people that were having allergic reaction to the Pfizer vaccine, so his leg and arm look just like the pictures so reporter's question was, are you guys giving any advice about how to treat these infection.  Follow-up (24Dec2021): This is a spontaneous follow up report received from a same contactable consumer. This consumer (patient's parent) reported for a male patient (reporter's son) that: Update Information: Patient age.  Follow-up (13Jan2022): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Headache
Clinical narrative: Headache; Chills; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Manufacturer unknown), for COVID-19 immunization.  The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "Headache"; CHILLS (non-serious), outcome "unknown", described as "Chills".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Burning sensation, Neuralgia, Pain
Clinical narrative: Shooting; burning sensation; nerve pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 5 year-old male patient received bnt162b2 (COMIRNATY), administered in arm left, administration date 01Dec2021 08:00 (Lot number: fk5818) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Comirnaty (Dose Number: 1, Batch/Lot No: ik5127, Vaccine Administration Time: 08:30 AM), administration date: 10Nov2021, when the patient was 5 years old, for Covid-19 Immunization.  The following information was reported: PAIN (non-serious) with onset 01Dec2021 19:00, outcome "not recovered", described as "Shooting"; BURNING SENSATION (non-serious) with onset 01Dec2021 19:00, outcome "not recovered", described as "burning sensation"; NEURALGIA (non-serious) with onset 01Dec2021 19:00, outcome "not recovered", described as "nerve pain".  Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Reported events included shooting, stabbing or burning sensation. It is presumably nerve pain. The (withheld) mon had similar pans but they stopped in 3 days after vaccination and (withheld) still has them 23 days after the second vaccination and they intensify. The patient was neither diagnosed with COVID-19 prior to vaccination nor tested for COVID-19 since the vaccination.  Follow-up attempts are completed. No further information is expected.